PharmAthene
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$15.0m | Series A | ||
$15.0m | Series A | ||
$50.0m | Series B | ||
N/A | N/A | IPO | |
$19.3m | Secondary | ||
N/A | Acquisition | ||
Total Funding | €72.7m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$15.0m | Series A | ||
$15.0m | Series A | ||
$50.0m | Series B | ||
N/A | N/A | IPO | |
$19.3m | Secondary | ||
N/A | Acquisition | ||
Total Funding | €72.7m |